Shenzhou Cell Investor Relations Activity Record Form (2023 Pharmaceutical Special Group Performance Briefing)
Shenzhou Cell Investor Relations Activity Record Form (May 16, 2024)
Announcement of Shenzhou Cell to participate in the 2023 Pharmaceutical Special Group Performance Briefing
Shenzhou Cell Investor Relations Activity Record Form (May 8, 2024)
CITIC Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Beijing Shenzhou Cell Biotechnology Group Co., Ltd.
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Shenzhou Cell
Legal Opinion of Beijing King & Wood Mallesons Law Firm on the 2023 Annual General Meeting of Shareholders of Beijing Shenzhou Cell Biotechnology Group Co., Ltd.
Shenzhou Cell Investor Relations Activity Record Form (May 6, 2024)
Shenzhou Cell Investor Relations Activity Record Form (April 30, 2024)
Announcement on the listing and circulation of restricted shares issued by Shenzhou Cell to specific targets
Inspection opinions of CITIC Securities Co., Ltd. on the listing and circulation of restricted shares issued by Beijing Shenzhou Cell Biotechnology Group Co., Ltd. to specific targets
Shenzhou Cell 2023 Annual Shareholders' Meeting Meeting Information
CITIC Securities Co., Ltd. report on the 2023 continuous supervision work site inspection report of Beijing Shenzhou Cell Biotechnology Group Co., Ltd.
Shenzhou Cell 2024 First Quarter Report
Voluntary disclosure notice on advance performance increase of Shenzhou Cell for the first quarter of 2024
Shenzhou Cell 2023 Annual Report
Shenzhou Cell 2023 Annual Report Summary
Shenzhou Cell 2023 Audit Report
Special audit report on the summary table of the non-operating capital occupation of Shenzhou Cell and other related financial transactions
Shenzhou Cell 2023 Independent Director Debriefing Report (What)
No Data